124499-34-9 Usage
Uses
Used in Chemical Research:
2-(1,4-DIOXA-SPIRO[4.5]DEC-8-YL)-ETHYLAMINE is used as a research chemical for studying its properties and potential interactions with other molecules, which can contribute to the advancement of chemical science.
Used in Pharmaceutical Development:
In the pharmaceutical industry, 2-(1,4-DIOXA-SPIRO[4.5]DEC-8-YL)-ETHYLAMINE is used as a lead compound for drug design. Its unique spirocyclic structure may offer novel biological activities that could be harnessed for the development of new therapeutic agents.
Further research and testing are essential to fully explore the properties and potential applications of 2-(1,4-DIOXA-SPIRO[4.5]DEC-8-YL)-ETHYLAMINE, including its efficacy, safety, and mechanism of action in various biological contexts.
Check Digit Verification of cas no
The CAS Registry Mumber 124499-34-9 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,2,4,4,9 and 9 respectively; the second part has 2 digits, 3 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 124499-34:
(8*1)+(7*2)+(6*4)+(5*4)+(4*9)+(3*9)+(2*3)+(1*4)=139
139 % 10 = 9
So 124499-34-9 is a valid CAS Registry Number.
124499-34-9Relevant academic research and scientific papers
Substituted Benzamides with Conformationally Restricted Side Chains. 5. Azabicyclo Derivatives as 5-HT4 Receptor Agonists and Gastric Motility Stimulants
King, Frank D.,Hadley, Michael S.,Joiner, Karen T.,Martin, Roger T.,Sanger, Gareth J.,et al.
, p. 683 - 689 (2007/10/02)
The syntheses of benzamides containing azabicyclo side chains and their 5-HT4 receptor agonist and 5-HT3 receptor antagonist properties are described.These compounds were designed to mimic higher energy conformations of quinol
2-(SUBSTITUTED AMINO) ADENOSINES AS ANTIHYPERTENSIVES
-
, (2008/06/13)
Disclosed are 2-substituted adenosine derivatives of the formula STR1 in which R represents a substituted amino grouping of the formula STR2 as defined herein; pharmaceutically acceptable ester derivatives thereof in which free hydroxy groups are esterified in the form of a pharmaceutically acceptable prodrug ester; and pharmaceutically acceptable salts thereof; pharmaceutical compositions comprising said compounds; methods for their preparation; and their use in mammals as therapeutically effective adenosine-2 (A-2) agonists.
